Jose Luis Magana, File, Associated Press
WASHINGTON — Questions are being raised about Medicare in the meningitis outbreak that has rekindled doubts about the safety of the nation's drug supply.
The health insurance program for seniors long ago flagged compounded drugs manufactured without Food and Drug Administration oversight as safety risks. The outbreak that has sickened more than 250 people nationally has been linked to an injectable steroid from a Massachusetts compounding pharmacy.
In 2007, Medicare revoked coverage of compounded inhaler drugs for lung disease, citing safety reasons.
But Medicare doesn't seem to have consistently used its power to deny payment, and critics say that enables the compounding industry to flourish.
Sen. Charles Grassley says Medicare has some explaining to do. The Iowa Republican says every avenue for preventing another crisis must be explored.
- A decade after welcoming wind, states reconsider
- 4 eccentric billionaire spending habits
- Chaffetz calls Secret Service resignation...
- Charging documents show Phelps DUI tied to...
- Jail ordered for Idaho man in FLDS abuse case
- Romney, Huntsman may both be taking...
- Man with Ebola virus flew roundabout trip to US
- Saudi overhaul reshapes Islam's holiest city...
- Romney, Huntsman may both be taking... 40
- Obama: US 'underestimated' Islamic... 24
- New mom Chelsea Clinton celebrates baby... 15
- Marijuana could deliver more than $800... 14
- Obama seeks traction on economy amid... 14
- Police: Fired worker beheaded Oklahoma... 13
- Chaffetz calls Secret Service... 13
- Obama goal of Gitmo closure stalled at... 10